These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

494 related items for PubMed ID: 31268127

  • 1. ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research.
    Marchiò C, Scaltriti M, Ladanyi M, Iafrate AJ, Bibeau F, Dietel M, Hechtman JF, Troiani T, López-Rios F, Douillard JY, Andrè F, Reis-Filho JS.
    Ann Oncol; 2019 Sep 01; 30(9):1417-1427. PubMed ID: 31268127
    [Abstract] [Full Text] [Related]

  • 2. Identification of NTRK gene fusions in lung adenocarcinomas in the Chinese population.
    Zhao R, Yao F, Xiang C, Zhao J, Shang Z, Guo L, Ding W, Ma S, Yu A, Shao J, Zhu L, Han Y.
    J Pathol Clin Res; 2021 Jul 01; 7(4):375-384. PubMed ID: 33768710
    [Abstract] [Full Text] [Related]

  • 3. Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing.
    Bourhis A, Caumont C, Quintin-Roué I, Magro E, Dissaux G, Remoué A, Le Noac'h P, Douet-Guilbert N, Seizeur R, Tyulyandina A, Schick U, Merlio JP, Marcorelles P, Cappellen D, Uguen A.
    Pathology; 2022 Feb 01; 54(1):55-62. PubMed ID: 34518039
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prevalence and detection methodology for preliminary exploration of NTRK fusion in gastric cancer from a single-center retrospective cohort.
    Dong K, Yin L, Wang Y, Jia L, Diao X, Huang X, Zhou L, Lin D, Sun Y.
    Hum Pathol; 2024 Jun 01; 148():87-92. PubMed ID: 38653403
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Identifying patients with NTRK fusion cancer.
    Solomon JP, Benayed R, Hechtman JF, Ladanyi M.
    Ann Oncol; 2019 Nov 01; 30(Suppl_8):viii16-viii22. PubMed ID: 31738428
    [Abstract] [Full Text] [Related]

  • 10. NTRK fusions and Trk proteins: what are they and how to test for them.
    Weiss LM, Funari VA.
    Hum Pathol; 2021 Jun 01; 112():59-69. PubMed ID: 33794242
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic testing approaches for the identification of patients with TRK fusion cancer prior to enrollment in clinical trials investigating larotrectinib.
    Rudzinski ER, Hechtman J, Roy-Chowdhuri S, Rudolph M, Lockwood CM, Silvertown J, Wierzbinska J, Shen K, Norenberg R, Nogai H, Hong DS, Drilon A, Laetsch TW.
    Cancer Genet; 2022 Jan 01; 260-261():46-52. PubMed ID: 34929613
    [Abstract] [Full Text] [Related]

  • 12. Molecular characterization of cancers with NTRK gene fusions.
    Gatalica Z, Xiu J, Swensen J, Vranic S.
    Mod Pathol; 2019 Jan 01; 32(1):147-153. PubMed ID: 30171197
    [Abstract] [Full Text] [Related]

  • 13. Testing algorithm for identification of patients with TRK fusion cancer.
    Penault-Llorca F, Rudzinski ER, Sepulveda AR.
    J Clin Pathol; 2019 Jul 01; 72(7):460-467. PubMed ID: 31072837
    [Abstract] [Full Text] [Related]

  • 14. Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions.
    Hechtman JF, Benayed R, Hyman DM, Drilon A, Zehir A, Frosina D, Arcila ME, Dogan S, Klimstra DS, Ladanyi M, Jungbluth AA.
    Am J Surg Pathol; 2017 Nov 01; 41(11):1547-1551. PubMed ID: 28719467
    [Abstract] [Full Text] [Related]

  • 15. Pan-tumor screening for NTRK gene fusions using pan-TRK immunohistochemistry and RNA NGS fusion panel testing.
    Koehne de González A, Mansukhani MM, Fernandes H, Hsiao SJ.
    Cancer Genet; 2022 Apr 01; 262-263():47-52. PubMed ID: 35007853
    [Abstract] [Full Text] [Related]

  • 16. Multidisciplinary consensus on optimising the detection of NTRK gene alterations in tumours.
    Garrido P, Hladun R, de Álava E, Álvarez R, Bautista F, López-Ríos F, Colomer R, Rojo F.
    Clin Transl Oncol; 2021 Aug 01; 23(8):1529-1541. PubMed ID: 33620682
    [Abstract] [Full Text] [Related]

  • 17. NTRK-Rearranged soft tissue neoplasms: A review of evolving diagnostic entities and algorithmic detection methods.
    Surrey LF, Davis JL.
    Cancer Genet; 2022 Jan 01; 260-261():6-13. PubMed ID: 34794069
    [Abstract] [Full Text] [Related]

  • 18. NTRK Fusions in Central Nervous System Tumors: A Rare, but Worthy Target.
    Gambella A, Senetta R, Collemi G, Vallero SG, Monticelli M, Cofano F, Zeppa P, Garbossa D, Pellerino A, Rudà R, Soffietti R, Fagioli F, Papotti M, Cassoni P, Bertero L.
    Int J Mol Sci; 2020 Jan 23; 21(3):. PubMed ID: 31979374
    [Abstract] [Full Text] [Related]

  • 19. Neurotrophic tyrosine receptor kinase gene fusions in adult and pediatric patients with solid tumors: a clinicogenomic biobank and record linkage study of expression frequency and patient characteristics from Finland.
    Zhang W, Schmitz AA, Kallionpää RE, Perälä M, Pitkänen N, Tukiainen M, Alanne E, Jöhrens K, Schulze-Rath R, Farahmand B, Zong J.
    Acta Oncol; 2024 Jul 05; 63():542-551. PubMed ID: 38967220
    [Abstract] [Full Text] [Related]

  • 20. Elaboration of NTRK-rearranged colorectal cancer: Integration of immunoreactivity pattern, cytogenetic identity, and rearrangement variant.
    Wu S, Liu Y, Shi X, Zhou W, Zeng X.
    Dig Liver Dis; 2023 Dec 05; 55(12):1757-1764. PubMed ID: 37142453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.